DNLI
Price
$12.86
Change
-$0.88 (-6.40%)
Updated
Apr 3, 02:35 PM (EDT)
Capitalization
2B
40 days until earnings call
JANX
Price
$27.30
Change
-$0.95 (-3.36%)
Updated
Apr 3, 02:45 PM (EDT)
Capitalization
1.67B
40 days until earnings call
Ad is loading...

DNLI vs JANX

Header iconDNLI vs JANX Comparison
Open Charts DNLI vs JANXBanner chart's image
Denali Therapeutics
Price$12.86
Change-$0.88 (-6.40%)
Volume$259
Capitalization2B
Janux Therapeutics
Price$27.30
Change-$0.95 (-3.36%)
Volume$100
Capitalization1.67B
DNLI vs JANX Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. JANX commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and JANX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (DNLI: $13.74 vs. JANX: $28.25)
Brand notoriety: DNLI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 298% vs. JANX: 83%
Market capitalization -- DNLI: $2B vs. JANX: $1.67B
DNLI [@Biotechnology] is valued at $2B. JANX’s [@Biotechnology] market capitalization is $1.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, JANX is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 5 TA indicator(s) are bullish while JANX’s TA Score has 4 bullish TA indicator(s).

  • DNLI’s TA Score: 5 bullish, 3 bearish.
  • JANX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than JANX.

Price Growth

DNLI (@Biotechnology) experienced а -0.51% price change this week, while JANX (@Biotechnology) price change was -6.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.32%. For the same industry, the average monthly price growth was -10.36%, and the average quarterly price growth was -14.47%.

Reported Earning Dates

DNLI is expected to report earnings on May 13, 2025.

JANX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2B) has a higher market cap than JANX($1.67B). DNLI YTD gains are higher at: -32.581 vs. JANX (-47.236). JANX has higher annual earnings (EBITDA): -96.79M vs. DNLI (-492.89M). JANX has more cash in the bank: 1.03B vs. DNLI (832M). JANX has less debt than DNLI: JANX (23M) vs DNLI (48.7M). JANX has higher revenues than DNLI: JANX (10.6M) vs DNLI (0).
DNLIJANXDNLI / JANX
Capitalization2B1.67B119%
EBITDA-492.89M-96.79M509%
Gain YTD-32.581-47.23669%
P/E RatioN/AN/A-
Revenue010.6M-
Total Cash832M1.03B81%
Total Debt48.7M23M212%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLIJANX
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGEKX12.630.11
+0.88%
Baillie Gifford International Growth K
GSXCX24.92N/A
N/A
abrdn US Small Cap Equity C
CDDRX34.31N/A
N/A
Columbia Dividend Income Inst2
VMCRX5.41N/A
N/A
Voya MidCap Opportunities Port R6
NEXIX28.94N/A
N/A
Shelton Sustainable Equity Institutional

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+11.80%
BEAM - DNLI
57%
Loosely correlated
+4.79%
ARWR - DNLI
56%
Loosely correlated
+3.97%
NTLA - DNLI
55%
Loosely correlated
+9.69%
RCKT - DNLI
54%
Loosely correlated
+8.43%
RGNX - DNLI
53%
Loosely correlated
+4.29%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with DNLI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
+5.37%
DNLI - JANX
46%
Loosely correlated
+11.80%
SKYE - JANX
41%
Loosely correlated
+2.14%
LGND - JANX
39%
Loosely correlated
+3.73%
OCUL - JANX
37%
Loosely correlated
+12.23%
NUVB - JANX
36%
Loosely correlated
+2.29%
More